X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (21) 21
cancer (14) 14
female (11) 11
humans (11) 11
sarcopenia (9) 9
aged (8) 8
breast cancer (8) 8
middle aged (8) 8
survival (8) 8
chemotherapy (7) 7
muscles (7) 7
adult (6) 6
adults (6) 6
body composition (6) 6
patients (6) 6
aged, 80 and over (5) 5
care and treatment (5) 5
comorbidity (5) 5
geriatric assessment (5) 5
male (5) 5
skeletal muscle index (5) 5
body mass (4) 4
hematology, oncology and palliative medicine (4) 4
musculoskeletal system (4) 4
skeletal muscle (4) 4
toxicity (4) 4
age (3) 3
body mass index (3) 3
body-composition (3) 3
body-mass index (3) 3
breast neoplasms - drug therapy (3) 3
breast neoplasms - pathology (3) 3
cancer patients (3) 3
geriatric oncology (3) 3
health aspects (3) 3
mass (3) 3
metastasis (3) 3
neoplasm metastasis (3) 3
pharmacokinetics (3) 3
prognosis (3) 3
research (3) 3
skeletal muscle gauge (3) 3
adjuvant chemotherapy (2) 2
age factors (2) 2
analysis (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
attenuation (2) 2
biomarkers (2) 2
biopsy (2) 2
breast neoplasms - diagnosis (2) 2
breast neoplasms - mortality (2) 2
cachexia (2) 2
cancer research (2) 2
colorectal cancer (2) 2
colorectal-cancer (2) 2
computed tomography (2) 2
decision-making (2) 2
determinant (2) 2
disease management (2) 2
erratum (2) 2
experimental design (2) 2
hospitalization (2) 2
kaplan-meier estimate (2) 2
lean body mass (2) 2
medicine & public health (2) 2
muscle attenuation (2) 2
muscle, skeletal - pathology (2) 2
myopenia (2) 2
neoplasm staging (2) 2
obesity (2) 2
physiological aspects (2) 2
predictors (2) 2
prevalence (2) 2
public, environmental & occupational health (2) 2
quality (2) 2
resection (2) 2
retrospective studies (2) 2
risk assessment (2) 2
risk factors (2) 2
sarcopenia - etiology (2) 2
skeletal muscle density (2) 2
skin and connective tissue diseases (2) 2
solid tumors (2) 2
statistics (2) 2
strength (2) 2
studies (2) 2
survival analysis (2) 2
taxane (2) 2
tomography, x-ray computed (2) 2
treatment outcome (2) 2
vertebrae (2) 2
women (2) 2
1st-line chemotherapy (1) 1
5-fluorouracil (1) 1
a-bomb survivors (1) 1
activities of daily living (1) 1
adenocarcinoma - complications (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - secondary (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. e220 - e220
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 2/2018, Volume 81, Issue 2, pp. 413 - 417
... on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer Grant R. Williams 1,2 · Allison M. Deal 2 · Shlomit Strulov Shachar 2,3 · Christine M. Walko 4 · Jai N... 
Skeletal muscle index | Sarcopenia | Medicine & Public Health | Oncology | Cancer Research | Pharmacology/Toxicology | Pharmacokinetics | Cancer | ONCOLOGY | PHARMACOLOGY & PHARMACY | BODY-COMPOSITION | CHEMOTHERAPY | AGE | Humans | Middle Aged | Sarcopenia - complications | Antibiotics, Antineoplastic - adverse effects | Male | Tomography, X-Ray Computed | Fluorouracil - therapeutic use | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Antibiotics, Antineoplastic - pharmacokinetics | Colorectal Neoplasms - metabolism | Bevacizumab - administration & dosage | Colorectal Neoplasms - diagnostic imaging | Obesity - metabolism | Antibiotics, Antineoplastic - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sarcopenia - pathology | Aged | Muscle, Skeletal - pathology | Fluorouracil - pharmacokinetics | Organoplatinum Compounds - therapeutic use | Muscles | Chemotherapy | Analysis | Colorectal cancer | Fluorouracil | 5-Fluorouracil | Toxicity | Colorectal carcinoma | Cytotoxicity | Dosage | Body composition | Bevacizumab | Infusion | Body composition (biology) | Lean body mass | Secondary analysis | Hematology | Pharmacology | Metabolism | Patients | Skeletal muscle | Musculoskeletal system | Body mass | Adults | Cytotoxic agents | Index Medicus | pharmacokinetics | cancer | skeletal muscle index | sarcopenia
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. e220 - e221
Journal Article
Clinical cancer research, ISSN 1557-3265, 2017, Volume 23, Issue 3, pp. 658 - 665
Purpose: Severe skeletal muscle (SM) loss (sarcopenia) is associated with poor cancer outcomes, including reduced survival and increased toxicity. This study... 
CACHEXIA | METAANALYSIS | SOLID TUMORS | PHARMACOKINETICS | ONCOLOGY | STATISTICS | COLORECTAL-CANCER | DETERMINANT | BODY-MASS INDEX | SARCOPENIA | PACLITAXEL | Body Composition | Prognosis | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Hospitalization - statistics & numerical data | Tomography, X-Ray Computed | Sarcopenia - chemically induced | Antineoplastic Agents, Phytogenic - administration & dosage | Sarcopenia - etiology | Aged, 80 and over | Adult | Female | Body Surface Area | Taxoids - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Body Mass Index | Kaplan-Meier Estimate | Proportional Hazards Models | Sarcopenia - diagnostic imaging | Organ Size | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Adenocarcinoma - complications | Adenocarcinoma - secondary | Breast Neoplasms - complications | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Muscle, Skeletal - diagnostic imaging | Breast Neoplasms - mortality | Aged | Muscle, Skeletal - pathology | Specific Gravity | Adenocarcinoma - mortality | Vertebrae | Toxicity | Test procedures | Muscles | Breast cancer | Metastasis | Taxane | Survival | Patients | Skeletal muscle | Metastases | Sarcopenia | Musculoskeletal system | Chemotherapy | Computed tomography | Experimental design | Quality | Cancer | toxicity | skeletal muscle index | skeletal muscle gauge | metastatic breast cancer | survival | taxane chemotherapy | muscle attenuation | hospitalizations | sarcopenia
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e12033 - e12033
e12033 Background: About 20% of breast cancers harbor an amplification and/ or overexpression of human epidermal growth factor receptor 2 (HER2).The treatment... 
Journal Article
Cancer epidemiology, biomarkers & prevention, ISSN 1055-9965, 06/2017, Volume 26, Issue 6, pp. 981 - 981
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e21010 - e21010
Journal Article
The breast journal, ISSN 1075-122X, 05/2018, Volume 24, Issue 3, pp. 441 - 443
Journal Article
NPJ breast cancer, ISSN 2374-4677, 2016, Volume 2, Issue 1, p. 16011
... care Shlomit Strulov Shachar1,2 and Hyman B Muss1 Internet tools have become a great aid in the daily practice of physicians who treat breast cancer patients... 
Journal Article
Current Geriatrics Reports, ISSN 2196-7865, 12/2017, Volume 6, Issue 4, pp. 213 - 218
...HEMA TOLOGY AND ONCOLOGY (GR WILLIAMS, SECTION EDITOR) Sarcopenia in Oncology or Gerontology: What Is the Difference? Shlomit Strulov Shachar 1,2 & Noa Shafran... 
Neurology | Sarcopenia | Pain Medicine | Medicine & Public Health | Geriatrics/Gerontology | Psychopharmacology | Rheumatology | Oncology | Medicine/Public Health, general | Body composition | Muscle mass
Journal Article
Journal of geriatric oncology, ISSN 1879-4068, 2018, Volume 9, Issue 9
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e21707 - e21707
e21707 Background: There is growing evidence in oncology that skeletal muscle (SM) loss, known as sarcopenia, can be identified from routine computed... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.